PMID: 9186825May 1, 1997Paper

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers

Journal of Hepatology
S W SchalmA Alberti

Abstract

This study aimed to obtain a more precise estimation of the efficacy and tolerability of interferon-ribavirin combination therapy for chronic hepatitis C. A meta-analysis was carried out of individual patient data comprising about 90% of the published experience with combination therapy. The study was set in four European university-affiliated liver referral centers. A total of 186 individuals with chronic hepatitis C who had participated in three randomized controlled trials and one open study were selected for the study. Fifty-one had received ribavirin monotherapy (1000-1200 mg/day), 37 interferon monotherapy (3 MU 3x/week) and 78 interferon-ribavirin combination therapy (dosage as for monotherapy) for 6 months. Twenty patients served as controls. Follow-up after therapy was 6 months. Data analysis was by the multivariate logistical regression method. The primary outcome measure for efficacy was the percentage with a sustained response (ALT normalization and HCV RNA negativity 6 months after therapy). The sustained response rate was significantly higher for interferon-ribavirin combination therapy than for interferon or ribavirin monotherapy (odds ratio IFN-Riba vs IFN = 9.8, 95% CI 1.9-50). The estimated probability of sust...Continue Reading

Citations

Oct 17, 1998·Clinical Reviews in Allergy & Immunology·A Della RossaS Bombardieri
Jul 3, 1999·Comprehensive Therapy·H J Fallon
Sep 12, 2000·Current Gastroenterology Reports·G L Davis
Aug 26, 1998·Antiviral Research·J W Cohen StuartR J Whitley
Jan 6, 2000·Journal of Hepatology·M Ruiz-MorenoA Millàn
Jan 6, 2000·Journal of Hepatology·O Weiland
Jan 6, 2000·Journal of Hepatology·S W SchalmT G van Rossum
Jan 6, 2000·Journal of Hepatology·M P Civeira, J Prieto
Mar 23, 2002·Bioorganic & Medicinal Chemistry Letters·Rumin ZhangWilliam T Windsor
Mar 10, 2001·Clinics in Liver Disease·H L Bonkovsky, R W Lambrecht
Dec 7, 2002·Microbes and Infection·Claudia O Zein, Nizar N Zein
Jan 6, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BresciA Capria
May 11, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M PuotiG Carosi
Feb 2, 2010·Nature Reviews. Drug Discovery·Daan CrommelinHubert Leufkens
Apr 10, 2010·Nature Reviews. Drug Discovery·Elizabeth J HennessyLuke A J O'Neill
Apr 12, 2000·Alimentary Pharmacology & Therapeutics·O Lo IaconoR Moreno-Otero
Feb 28, 2002·Alimentary Pharmacology & Therapeutics·J A Moreno-MonteagudoR Moreno-Otero
Aug 29, 2002·Alimentary Pharmacology & Therapeutics·C H ChangK A Chan
Jun 10, 2000·The British Journal of Dermatology·I AntunesG MacEdo
Oct 29, 1998·British Journal of Haematology·P L Giangrande
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·G M Dusheiko
May 8, 1998·Journal of Viral Hepatitis·J MoussalliT Poynard
Apr 12, 2000·Journal of Viral Hepatitis·S Sherlock

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.